Company: FCRS
Filing Date: 2025-09-05
Form Type: S-1
Source: 0001213900-25-085160
Chunk: 160

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-05
Form: S-1
Chunk 160
---
. He is also an adjunct professor at Fordham Gabelli School of Business, teaching venture capital investing to graduate students. Since August 2025, he has been the Chief Financial officer of Kin Euphorics, a private non -alcoholicbeverage company. Prior to m1720, Mr. Tsang spent 10 years at HSBC (LSE: HSBA) based in Hong Kong. From 2012 to 2018, he was the head of China Internet research and then global head of e -commerceresearch. Mr. Tsang focused his research on e -commerce, including Alibaba (NYSE: BABA) and Tencent (HKEX: 0700) and Trip.com (NASDAQ: TCOM). From 2018 to 2022, Mr. Tsang was the head of Telecom, Media and Technology investment banking for Asia -Pacat HSBC. Before relocating to Hong Kong, Mr. Tsang spent a decade on the buyside in New York City. Mr. Tsang was the global head of technology research at Neuberger Berman from 2000 to 2008. From 2009 to 2011, he 102 was the senior China analyst for 1798 Global Partners, where he was responsible for long -onlyand long -shortinvestments for greater China region. Mr. Tsang received his Bachelor of Science from Cornell University in Policy Analysis and his Master of Business Administration from the Fordham Gabelli School of Business. He is a CFA charterholder. Eric Semlerwill serve as an independent director upon commencement of trading of our securities on Nasdaq. He is a public and private market investor in technology and media. His long/short investment fund, TCS, which he founded in 2001 and converted into a family office in 2017. Mr. Semler has helped unlock value for several public companies as an active shareholder and/or board member. Since July 2025, he has served as Chief Executive Officer and Chairman of the Board of Trailblazer Acquisition Corp., a blank check company currently in registration with the SEC. Since April 2023 he has served Chairman of the Board of Semler Scientific, Inc. (NASDAQ: SMLR), a medical device and software business and the second U.S. public company to adopt bitcoin as its primary treasury reserve asset. Since 2021, he has served on the board of Fundstrat. Mr. Semler has previously served on three public company boards